Nhan Huynh1, Joshua D Rouch1, Andrew Scott1, Elvin Chiang1, Benjamin M Wu2, Shant Shekherdimian1, James C Y Dunn3. 1. Department of Surgery, Division of Pediatric Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. 2. School of Engineering, Department of Bioengineering, University of California Los Angeles, Los Angeles, CA, 90095, USA. 3. Department of Surgery, Division of Pediatric Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA; School of Engineering, Department of Bioengineering, University of California Los Angeles, Los Angeles, CA, 90095, USA. Electronic address: jdunn@mednet.ucla.edu.
Abstract
PURPOSE: Distraction enterogenesis has been investigated as a novel treatment for patients with short bowel syndrome (SBS) but has been limited by loss of intestinal length during restoration and need for multiple bowel surgeries. The feasibility of in-continuity, spring-mediated intestinal lengthening has yet to be demonstrated. METHODS: Juvenile mini-Yucatan pigs underwent in-continuity placement of polycaprolactone (PCL) degradable springs within jejunum. Methods used to anchor the spring ends to the intestine included full-thickness sutures and a high-friction surface spring. Spring constant (k) was 6-15N/m. Bowel was examined for length and presence of spring at 1 to 4weeks. RESULTS: Animals tolerated in-continuity lengthening without bowel obstruction for up to 29days. In-continuity jejunum with springs demonstrated intestinal lengthening by 1.47-fold ±0.11. Five springs had detached prematurely, and lengthening could not be assessed. Histologically, in-continuity jejunum showed significantly increased crypt depth and muscularis thickness in comparison to normal jejunum. CONCLUSION: Self-expanding endoluminal springs placed in continuity could lengthen intestine without obstruction in a porcine model. This is the first study showing safety and efficacy of a self-expanding endoluminal device for distraction enterogenesis. This is proof-of-concept that in-continuity spring lengthening is feasible and demonstrates its therapeutic potential in SBS. LEVEL OF EVIDENCE: Level 3. Copyright Â
PURPOSE: Distraction enterogenesis has been investigated as a novel treatment for patients with short bowel syndrome (SBS) but has been limited by loss of intestinal length during restoration and need for multiple bowel surgeries. The feasibility of in-continuity, spring-mediated intestinal lengthening has yet to be demonstrated. METHODS: Juvenile mini-Yucatan pigs underwent in-continuity placement of polycaprolactone (PCL) degradable springs within jejunum. Methods used to anchor the spring ends to the intestine included full-thickness sutures and a high-friction surface spring. Spring constant (k) was 6-15N/m. Bowel was examined for length and presence of spring at 1 to 4weeks. RESULTS: Animals tolerated in-continuity lengthening without bowel obstruction for up to 29days. In-continuity jejunum with springs demonstrated intestinal lengthening by 1.47-fold ±0.11. Five springs had detached prematurely, and lengthening could not be assessed. Histologically, in-continuity jejunum showed significantly increased crypt depth and muscularis thickness in comparison to normal jejunum. CONCLUSION: Self-expanding endoluminal springs placed in continuity could lengthen intestine without obstruction in a porcine model. This is the first study showing safety and efficacy of a self-expanding endoluminal device for distraction enterogenesis. This is proof-of-concept that in-continuity spring lengthening is feasible and demonstrates its therapeutic potential in SBS. LEVEL OF EVIDENCE: Level 3. Copyright Â
Authors: S Clayton; J S Alexander; G Solitro; L White; S Villalba; E Winder; M Boudreaux; P Veerareddy; E Dong; A Minagar; H N Dao; D Sorrells Journal: Pediatr Surg Int Date: 2021-10-28 Impact factor: 1.827
Authors: Katherine I Portelli; Jun-Beom Park; Jordan S Taylor; Anne-Laure Thomas; Matthias Stelzner; Martin G Martin; James C Y Dunn Journal: J Pediatr Surg Date: 2020-06-30 Impact factor: 2.545
Authors: Julian L Muff; Filipp Sokolovski; Zarah Walsh-Korb; Rashikh A Choudhury; James C Y Dunn; Stefan G Holland-Cunz; Raphael N Vuille-Dit-Bille Journal: Children (Basel) Date: 2022-07-10
Authors: Talha A Rafeeqi; Anne-Laure Thomas; Fereshteh Salimi-Jazi; Modupeola Diyaolu; James C Y Dunn Journal: PLoS One Date: 2022-09-15 Impact factor: 3.752
Authors: Nhan Huynh; Genia Dubrovsky; Joshua D Rouch; Andrew Scott; Elvin Chiang; Tommy Nguyen; Benjamin M Wu; Shant Shekherdimian; Thomas M Krummel; James C Y Dunn Journal: PLoS One Date: 2018-07-12 Impact factor: 3.240